BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34861419)

  • 21. Genetics and epigenetics of human retinoblastoma.
    Benavente CA; Dyer MA
    Annu Rev Pathol; 2015; 10():547-62. PubMed ID: 25621664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of circular RNA expression associated with human retinoblastoma.
    Lyu J; Wang Y; Zheng Q; Hua P; Zhu X; Li J; Li J; Ji X; Zhao P
    Exp Eye Res; 2019 Jul; 184():278-285. PubMed ID: 30917906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
    Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
    Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Genetics of Intraocular Tumors.
    Hanbazazh M; Dryja TP
    Semin Ophthalmol; 2020 Apr; 35(3):174-181. PubMed ID: 32507011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation of adenomatosis polyposis coli-2 and its tumor suppressor role in retinoblastoma.
    Beta M; Chitipothu S; Khetan V; Biswas J; Krishnakumar S
    Curr Eye Res; 2015 Jul; 40(7):719-28. PubMed ID: 25207834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
    Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
    Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Noncoding RNA LINC00202 Promotes Tumor Progression by Sponging miR-3619-5p in Retinoblastoma.
    Yan G; Su Y; Ma Z; Yu L; Chen N
    Cell Struct Funct; 2019; 44(1):51-60. PubMed ID: 30905893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal cell cycle regulation in primary human uveal melanoma cultures.
    Pardo M; Piñeiro A; de la Fuente M; García A; Prabhakar S; Zitzmann N; Dwek RA; Sánchez-Salorio M; Domínguez F; Capeans C
    J Cell Biochem; 2004 Nov; 93(4):708-20. PubMed ID: 15660415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
    Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
    Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spliceosome Mutations in Uveal Melanoma.
    Nguyen JQN; Drabarek W; Yavuzyigitoglu S; Medico Salsench E; Verdijk RM; Naus NC; de Klein A; Kiliç E; Brosens E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eye cancer: unique insights into oncogenesis: the Cogan Lecture.
    Harbour JW
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1736-45. PubMed ID: 16638975
    [No Abstract]   [Full Text] [Related]  

  • 32. RNA Sequencing and Bioinformatic Analysis on Retinoblastoma Revealing that Cell Cycle Deregulation Is a Key Process in Retinoblastoma Tumorigenesis.
    Nie C; Ma H; Gao Y; Li J; Tang Z; Chen Y; Lu R
    Ophthalmologica; 2021; 244(1):51-59. PubMed ID: 32146475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
    Yang B; Gu A; Wu Y
    Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation of human retinoblastoma.
    Singh U; Malik MA; Goswami S; Shukla S; Kaur J
    Tumour Biol; 2016 Nov; 37(11):14427-14441. PubMed ID: 27639385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-Wide Analysis of Uveal Melanoma Metastasis-Associated LncRNAs and Their Functional Network.
    Xu B; Ma R; Ren H; Qian J
    DNA Cell Biol; 2018 Feb; 37(2):99-108. PubMed ID: 29240458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.
    Anestopoulos I; Kyriakou S; Tragkola V; Paraskevaidis I; Tzika E; Mitsiogianni M; Deligiorgi MV; Petrakis G; Trafalis DT; Botaitis S; Giatromanolaki A; Koukourakis MI; Franco R; Pappa A; Panayiotidis MI
    Pharmacol Ther; 2022 Dec; 240():108301. PubMed ID: 36283453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of new therapeutic options for the treatment of uveal melanoma.
    Wang JZ; Lin V; Toumi E; Wang K; Zhu H; Conway RM; Madigan MC; Murray M; Cherepanoff S; Zhou F; Shu W
    FEBS J; 2021 Nov; 288(21):6226-6249. PubMed ID: 33838075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the
    Raizis AM; Racher HM; Foucal A; Dimaras H; Gallie BL; George PM
    Epigenetics; 2021 Sep; 16(9):940-954. PubMed ID: 33258708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic drug library screening reveals targeting DOT1L abrogates NAD
    Gu X; Hua Y; Yu J; Yang L; Ge S; Jia R; Chai P; Zhuang A; Fan X
    J Pharm Anal; 2023 Jan; 13(1):24-38. PubMed ID: 36820078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.